Found: 10
Select item for more details and to access through your institution.
Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8245, doi. 10.3390/ijms21218245
- By:
- Publication type:
- Article
Imaging P-glycoprotein Induction at the Blood-Brain Barrier of a Beta-Amyloidosis Mouse Model with <sup>11</sup>C-Metoclopramide PET.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.237198
- By:
- Publication type:
- Article
Serial Quantitative TSPO-Targeted PET Reveals Peak Microglial Activation up to 2 Weeks After an Epileptogenic Brain Insult.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1302, doi. 10.2967/jnumed.116.172494
- By:
- Publication type:
- Article
Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2020, v. 40, n. 1, p. 204, doi. 10.1177/0271678X18809886
- By:
- Publication type:
- Article
Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer's Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 331, doi. 10.3390/biom13020331
- By:
- Publication type:
- Article
ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer's Disease.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 7, p. 932, doi. 10.3390/biology12070932
- By:
- Publication type:
- Article
Isotope‐labeled amyloid‐β does not transmit to the brain in a prion‐like manner after peripheral administration.
- Published in:
- EMBO Reports, 2022, v. 23, n. 7, p. 1, doi. 10.15252/embr.202154405
- By:
- Publication type:
- Article
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
- Published in:
- Drugs in R&D, 2020, v. 20, n. 3, p. 197, doi. 10.1007/s40268-020-00316-1
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 8, p. 2597, doi. 10.1007/s11011-021-00843-z
- By:
- Publication type:
- Article
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
- Published in:
- Antioxidants, 2023, v. 12, n. 8, p. 1564, doi. 10.3390/antiox12081564
- By:
- Publication type:
- Article